Price to Book Value (P/BV)
since 2005
Calculation
Boston Scientific Corp., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Stockholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | 3.85 | = | 47.18 | ÷ | 12.25 | 12.25 | = | 17,573 | ÷ | 1,434,780,104 | |
| Feb 23, 2022 | 3.75 | = | 43.71 | ÷ | 11.65 | 11.65 | = | 16,622 | ÷ | 1,426,724,712 | |
| Feb 23, 2021 | 3.58 | = | 38.75 | ÷ | 10.81 | 10.81 | = | 15,326 | ÷ | 1,417,165,707 | |
| Feb 25, 2020 | 4.02 | = | 39.91 | ÷ | 9.94 | 9.94 | = | 13,877 | ÷ | 1,396,195,349 | |
| Feb 19, 2019 | 6.33 | = | 39.86 | ÷ | 6.30 | 6.30 | = | 8,726 | ÷ | 1,385,961,926 | |
| Feb 20, 2018 | 5.26 | = | 26.83 | ÷ | 5.10 | 5.10 | = | 7,012 | ÷ | 1,374,910,797 | |
| Feb 23, 2017 | 4.96 | = | 24.48 | ÷ | 4.94 | 4.94 | = | 6,733 | ÷ | 1,363,488,640 | |
| Feb 24, 2016 | 3.70 | = | 17.33 | ÷ | 4.69 | 4.69 | = | 6,320 | ÷ | 1,348,346,253 | |
| Feb 25, 2015 | 3.49 | = | 16.92 | ÷ | 4.85 | 4.85 | = | 6,457 | ÷ | 1,330,512,367 | |
| Feb 26, 2014 | 2.70 | = | 13.34 | ÷ | 4.94 | 4.94 | = | 6,539 | ÷ | 1,324,192,809 | |
| Feb 22, 2013 | 1.46 | = | 7.37 | ÷ | 5.06 | 5.06 | = | 6,870 | ÷ | 1,357,426,289 | |
| Feb 17, 2012 | 0.78 | = | 6.09 | ÷ | 7.82 | 7.82 | = | 11,353 | ÷ | 1,451,346,240 | |
| Feb 17, 2011 | 1.00 | = | 7.40 | ÷ | 7.42 | 7.42 | = | 11,296 | ÷ | 1,523,368,979 | |
| Feb 26, 2010 | 0.95 | = | 7.74 | ÷ | 8.14 | 8.14 | = | 12,301 | ÷ | 1,511,368,790 | |
| Feb 27, 2009 | 0.80 | = | 7.02 | ÷ | 8.77 | 8.77 | = | 13,174 | ÷ | 1,502,237,400 | |
| Feb 28, 2008 | 1.26 | = | 12.72 | ÷ | 10.12 | 10.12 | = | 15,097 | ÷ | 1,492,320,521 | |
| Mar 1, 2007 | 1.57 | = | 16.21 | ÷ | 10.33 | 10.33 | = | 15,298 | ÷ | 1,480,340,219 | |
| Mar 1, 2006 | 4.60 | = | 24.00 | ÷ | 5.21 | 5.21 | = | 4,282 | ÷ | 821,567,300 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Boston Scientific Corp. Annual Report.
- Share Price Trend
- The share price experienced a notable decline from $24 in 2006 to a low point of $6.09 in 2012, indicating a prolonged period of depreciation. From 2013 onwards, the share price showed a consistent upward trend, rising significantly to reach $47.18 by 2023. This recovery and growth phase reflects increased market valuation and investor confidence over the last decade.
- Book Value Per Share (BVPS) Trend
- Book value per share initially rose sharply from $5.21 in 2006 to a peak of $10.33 in 2007, before gradually declining to $4.69 in 2016. Since 2017, BVPS has demonstrated steady growth, climbing to $12.25 by 2023. The early volatility followed by sustained increase suggests improvements in the company’s net asset base or equity over recent years.
- Price-to-Book Value (P/BV) Ratio Trend
- The P/BV ratio showed a strong contraction from 4.6 in 2006 down to a trough of 0.78 in 2012, reflecting the period when share price was underperforming relative to book value. As the share price recovered from 2013 onwards, the P/BV ratio escalated sharply, peaking at 6.33 in 2019. Subsequently, it moderated somewhat but remained elevated above 3.5 through 2023, indicating that the market continued to price the shares at a premium over book value.
- Overall Insights
- The data reveals an early period (2006-2012) characterized by declining share price and P/BV ratio, despite relatively stable or fluctuating book value. This may indicate challenges faced by the company impacting investor sentiment. From 2013 onwards, both the share price and BVPS increased, with the share price appreciating more rapidly, resulting in a rising P/BV ratio and signaling improved market optimism and potentially enhanced financial performance or growth prospects.
Comparison to Competitors
Boston Scientific Corp., P/BV, long-term trends, comparison to competitors
| Boston Scientific Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 23, 2023 | 3.85 | 5.06 | 1,553,040.70 | 7.78 | 2.24 | 5.81 |
| Feb 23, 2022 | 3.75 | 5.75 | 3.07 | 8.59 | 3.26 | 6.27 |
| Feb 23, 2021 | 3.58 | 6.65 | 2.19 | 9.53 | 2.48 | 4.83 |
| Feb 25, 2020 | 4.02 | 4.96 | 2.42 | 8.13 | 2.66 | 4.92 |
| Feb 19, 2019 | 6.33 | 4.38 | 2.82 | 8.96 | 2.31 | 4.89 |
| Feb 20, 2018 | 5.26 | 3.40 | 2.24 | 9.91 | 2.40 | 4.59 |
| Feb 23, 2017 | 4.96 | 3.76 | 1.72 | 4.73 | 2.25 | 3.98 |
| Feb 24, 2016 | 3.70 | 2.68 | 1.44 | 4.67 | 2.04 | 3.12 |
| Feb 25, 2015 | 3.49 | 3.32 | 1.62 | 5.55 | 3.27 | 3.20 |
| Feb 26, 2014 | 2.70 | 2.38 | 1.00 | 4.37 | 2.78 | 2.16 |
| Feb 22, 2013 | 1.46 | 2.06 | 0.79 | 6.43 | 2.23 | 1.88 |
| Feb 17, 2012 | 0.78 | 3.61 | 0.95 | 7.31 | 2.59 | 1.96 |
| Feb 17, 2011 | 1.00 | 3.24 | 1.06 | 6.34 | 2.68 | 1.80 |
| Feb 26, 2010 | 0.95 | 3.69 | 1.06 | 8.22 | 2.89 | 1.60 |
| Feb 27, 2009 | 0.80 | 4.78 | 0.96 | 3.55 | 5.03 | 1.67 |
| Feb 28, 2008 | 1.26 | 4.83 | 1.75 | 12.99 | 5.31 | 2.98 |
| Mar 1, 2007 | 1.57 | 5.88 | 2.02 | 7.10 | 5.78 | 3.51 |
| Mar 1, 2006 | 4.60 | 4.69 | 2.04 | 7.80 | 6.06 | 4.50 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Boston Scientific Corp., P/BV, long-term trends, comparison to sector (health care equipment & services)
| Boston Scientific Corp. | Health Care Equipment & Services | |
|---|---|---|
| Feb 23, 2023 | 3.85 | 263,051.14 |
| Feb 23, 2022 | 3.75 | 5.01 |
| Feb 23, 2021 | 3.58 | 4.30 |
| Feb 25, 2020 | 4.02 | 4.00 |
| Feb 19, 2019 | 6.33 | 3.83 |
| Feb 20, 2018 | 5.26 | 3.44 |
| Feb 23, 2017 | 4.96 | 2.95 |
| Feb 24, 2016 | 3.70 | 2.39 |
| Feb 25, 2015 | 3.49 | 2.94 |
| Feb 26, 2014 | 2.70 | 2.12 |
| Feb 22, 2013 | 1.46 | 1.89 |
| Feb 17, 2012 | 0.78 | 2.39 |
| Feb 17, 2011 | 1.00 | 2.21 |
| Feb 26, 2010 | 0.95 | 2.31 |
| Feb 27, 2009 | 0.80 | 2.78 |
| Feb 28, 2008 | 1.26 | 3.52 |
| Mar 1, 2007 | 1.57 | 3.80 |
| Mar 1, 2006 | 4.60 | 3.90 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Boston Scientific Corp., P/BV, long-term trends, comparison to industry (health care)
| Boston Scientific Corp. | Health Care | |
|---|---|---|
| Feb 23, 2023 | 3.85 | 87,112.79 |
| Feb 23, 2022 | 3.75 | 5.48 |
| Feb 23, 2021 | 3.58 | 5.37 |
| Feb 25, 2020 | 4.02 | 5.14 |
| Feb 19, 2019 | 6.33 | 5.17 |
| Feb 20, 2018 | 5.26 | 4.55 |
| Feb 23, 2017 | 4.96 | 4.06 |
| Feb 24, 2016 | 3.70 | 3.62 |
| Feb 25, 2015 | 3.49 | 4.10 |
| Feb 26, 2014 | 2.70 | 3.51 |
| Feb 22, 2013 | 1.46 | 2.87 |
| Feb 17, 2012 | 0.78 | 2.51 |
| Feb 17, 2011 | 1.00 | 2.24 |
| Feb 26, 2010 | 0.95 | 2.36 |
| Feb 27, 2009 | 0.80 | 2.65 |
| Feb 28, 2008 | 1.26 | 3.45 |
| Mar 1, 2007 | 1.57 | 3.81 |
| Mar 1, 2006 | 4.60 | 3.97 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).